Dexcom (DXCM) Tax Provisions (2012 - 2026)

Dexcom (DXCM) has reported Tax Provisions for 13 consecutive years, with $68.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Provisions rose 11.58% year-over-year to $68.4 million in Q2 2026; TTM through Jun 2026 was $280.3 million, a 31.84% increase from a year earlier, with the FY2025 full-year figure at $252.1 million, up 89.83% from the prior year.
• Tax Provisions was $68.4 million for Q2 2026 at Dexcom, down from $70.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $119.7 million in Q3 2023 and troughed at -$61.2 million in Q1 2022.
• A 5-year average of $41.2 million and a median of $44.6 million in 2022 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions tumbled 302.63% in 2022 and soared 690.1% in 2024, its largest moves.
• Over 5 years, Tax Provisions stood at $41.4 million in 2022, then slumped by 124.4% to -$10.1 million in 2023, then soared by 690.1% to $59.6 million in 2024, then advanced by 23.15% to $73.4 million in 2025, then fell by 6.81% to $68.4 million in 2026.
• The last three Tax Provisions figures came in at $68.4 million (Q2 2026), $70.0 million (Q1 2026), and $73.4 million (Q4 2025), per Business Quant data.